Development of a new carrier for cyclosporine a with selectivity for lymphatics
Takada, K.; Furuya, Y.; Nakata, T.; Yoshikawa, H.; Muranishi, S.; Yasumura, T.; Oka, T.
Transplantation Proceedings 19(1 Part 2): 1711-1712
1987
ISSN/ISBN: 0041-1345 PMID: 3274409 Document Number: 296301
Document emailed within 1 workday
Related Documents
Kurlansky, P.A.; Sadeghi, A.M.; Michler, R.E.; Coppey, L.J.; Re, L.P.; Thomas, W.G.; Smith, C.R.; Reemtsma, K.; Rose, E.A. 1986: Role of the carrier solution in cyclosporine pharmacokinetics in the baboon Journal of Heart Transplantation 5(4): 312-316Adams, A.M.; Rabbani, A.; Ahmed, S.; Mahmood, S.S.; Al-Sabir, A.; Rashid, S.F.; Evans, T.G. 2013: Explaining equity gains in child survival in Bangladesh: scale, speed, and selectivity in health and development Lancet 382(9909): 2027-2037
Robbins, S.; Chuang, V.P.; Hersh, T. 1988: The development of hepatobiliary cancer in a carrier of Salmonella typhus American Journal of Gastroenterology 83(6): 675-678
Herrmann, R.P.; Sulway, M.J. 1973: A study of the selectivity of action of oxyphencyclimine hydrochloride on gastric secretion. (selectivity of oxyphencyclimine) Current Therapeutic Research 15(6): 291-297
Caner, M.üg.; Arat, S.; Bircan, R. 2008: Development of a hepatitis B virus carrier transgenic mice model Mikrobiyoloji Bulteni 42(1): 71-81
Vozianova, Z.I. 1971: Carrier state of Entamoeba histolytica and its role in the development of intestinal diseases Vrachebnoe Delo 11: 139-140
Miyagawa, N.; Miyagawa, S.; Ishii, H.; Hayashi, K.; Sakamoto, K.; Aoki, T. 1978: Studies on carrier protein in contact dermatitis: localization of soluble epidermal carrier proteins by macrophage migration test Acta Dermato-Venereologica 58(1): 23-27
Boulay, F.; Brandolin, G.; Vignais, P.V. 1986: 6'-O-dansyl-gamma-aminobutyryl atractyloside, a fluorescent probe of the ADP/ATP carrier: exploration of conformational changes of the membrane-bound ADP/ATP carrier elicited by substrates and inhibitors Biochemical and Biophysical Research Communications 134(1): 266-271
Mihatsch, M.J.; Steiner, K.; Abeywickrama, K.H.; Landmann, J.; Thiel, G. 1988: Risk factors for the development of chronic cyclosporine-nephrotoxicity Clinical Nephrology 29(4): 165-175
Ijichi, M.; Inaba, N.; Takamizawa, H.; Ohkawa, R. 1987: Combined passive and active immunization for preventing the development of the infantile carrier state in hepatitis B virus vertical transmission Nihon Sanka Fujinka Gakkai Zasshi 39(2): 263-270
Heidecke, C.D.; Nicolaus, C.; Stadler, J.; Florack, G.; Bollschweiler, E.; Hölscher, M. 1987: Measurement of cyclosporine bioactivity in serum of renal transplant recipients: development and comparison with RIA Transplantation Proceedings 19(1 Part 2): 1734-1736
Gruber, S.A.; Skjei, K.L.; Sothern, R.B.; Robison, L.; Tzardis, P.; Moss, A.; Gillingham, K.; Canafax, D.M.; Matas, A.J.; Dunn, D.L. 1991: Cancer development in renal allograft recipients treated with conventional and cyclosporine immunosuppression Transplantation Proceedings 23(1 Pt 2): 1104-1105
Khalid, M.; Bokhari, T.H.; Ahmad, M.; Bhatti, H.N.; Iqbal, M.; Ghaffar, A.; Qadir, M.I. 2014: Evaluation of carrier added and no carrier added 90Y-EDTMP as bone seeking therapeutic radiopharmaceutical Pakistan Journal of Pharmaceutical Sciences 27(4): 813-818
Sheil, A.G.; Disney, A.P.; Mathew, T.H.; Amiss, N.; Excell, L. 1991: Cancer development in cadaveric donor renal allograft recipients treated with azathioprine (AZA) or cyclosporine (CyA) or AZA/CyA Transplantation Proceedings 23(1 Part 2): 1111-1112
Morozumi, K.; Thiel, G.; Albert, F.W.; Banfi, G.; Gudat, F.; Mihatsch, M.J. 1992: Studies on morphological outcome of cyclosporine-associated arteriolopathy after discontinuation of cyclosporine in renal allografts Clinical Nephrology 38(1): 1-8
Lorber, M.I.; Flechner, S.M.; Van Buren, C.T.; Kerman, R.H.; Kahan, B.D. 1985: Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients Transplantation Proceedings 17(4 Suppl 1: 282-285
Dieperink, H.; Kemp, E.; Leyssac, P.P.; Starklint, H.; Wanscher, M.; Nielsen, J.; Jørgensen, K.A.; Faber, V.; Flachs, H. 1986: Ketoconazole and cyclosporine A: combined effects on rat renal function and on serum and tissue cyclosporine a concentration Clinical Nephrology 25(Suppl 1): S137-S143
Anderson, J.E.; Morris, R.E.; Blaschke, T.F. 1987: Pharmacodynamics of cyclosporine-ketoconazole interaction in mice. Combined therapy potentiates cyclosporine immunosuppression and toxicity Transplantation 43(4): 529-533
Mrowietz, U.; Christophers, E. 1988: Effects of cyclosporine a treatment on psoriasis. I: Influence of low-dose cyclosporine on human monocyte function in vitro Transplantation Proceedings 20(3 Suppl 4: 53-57
Diliz, H.S.; Olivera, M.A.; Kershenobich, D.; Mercado, M.A.; Orozco, H. 1996: Change of conventional cyclosporine to neoral cyclosporine formulation in long-term liver transplant recipients Transplantation Proceedings 28(6): 3348-3350